Vaccines market revenue Indonesia 2020-2029

The revenue in the 'Vaccines' segment of the pharmaceuticals market in Indonesia was forecast to decrease between 2024 and 2029 by in total 191.3 million U.S. dollars (-30.65 percent). This overall decrease does not happen continuously, notably not in 2028 and 2029. The indicator is estimated to amount to 432.97 million U.S. dollars in 2029. The Statista Market Insights cover a broad range of additional markets.

在印度尼西亚医药市场疫苗细分领域的收入预计将在2024年至2029年间总计下降19.13亿美元（-30.65%）。整体下降并非持续发生，尤其是2028年和2029年并非如此。预计到2029年，该指标将达到4.3297亿美元。Statista市场洞察覆盖了广泛的其它市场领域。